Anavex Life Sciences Corp (AVXL)

[boi568]

Wasn't the original endpoint just "change in cognition"? That gives no guidance whether the change is up or down. Using the new language specifies a direction and solves that minor issue. It also happens to line up with the terms that were used in reporting the Lecanemab results, allowing for an apples to apples comparison.

There has been no suggestion offered, other than by the usual trolls, that the endpoint change implies a lowering of the goalposts. I still think only a troll would try to play that card. Are you trying to play that card?